Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 3/20 | 0.57 |
| ▸ | RARB | P10826 | 2/20 | 0.43 |
| ▸ | RARA | P10276 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 5/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 8/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19794869 | 0.92 | THRB (0.48) | THRBRARBRARATSHRALDH1A1 | |
| SCHEMBL21917766 | 0.91 | THRB (0.50) | THRBRARBRARATSHRALDH1A1 | |
| SCHEMBL21342384 | 0.88 | THRB (0.45) | THRBRARBRARATSHRALDH1A1 | |
| SCHEMBL19801498 | 0.88 | THRB (0.44) | THRBRARBRARATSHRALDH1A1 | |
| SCHEMBL19794838 | 0.86 | THRB (0.44) | THRBRARBRARATSHRALDH1A1 | |
| SCHEMBL9418508 | 0.86 | THRB (0.75) | THRBRARBTSHRALDH1A1TP53 | |
| SCHEMBL25796355 | 0.85 | THRB (0.65) | THRBTSHRALDH1A1TP53HIF1A | |
| SCHEMBL24804854 | 0.84 | THRB (0.69) | THRBRARBRARATSHRALDH1A1 | |
| SCHEMBL25123471 | 0.84 | THRB (0.60) | THRBRARBRARATSHRALDH1A1 | |
| SCHEMBL25796428 | 0.84 | THRB (0.60) | THRBRARBRARATSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11066602-B2 | Reactive mesogen and liquid crystal composition including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-07-20 | — | — | US | disclosed |
| EP-3293245-B1 | REACTIVE MESOGEN AND LIQUID CRYSTAL COMPOSITION INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD (KR) | 2020-04-15 | — | — | EP | disclosed |
| US-20190276741-A1 | REACTIVE MESOGEN AND LIQUID CRYSTAL COMPOSITION INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-09-12 | — | — | US | disclosed |
| US-10344213-B2 | Reactive mesogen and liquid crystal composition including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-07-09 | — | — | US | disclosed |
| EP-3293245-A2 | REACTIVE MESOGEN AND LIQUID CRYSTAL COMPOSITION INCLUDING THE SAME | Samsung Display Co., Ltd. (KR) | 2018-03-14 | — | — | EP | disclosed |
| US-20180023000-A1 | REACTIVE MESOGEN AND LIQUID CRYSTAL COMPOSITION INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-01-25 | — | — | US | disclosed |
| US-20180023000-A1 | REACTIVE MESOGEN AND LIQUID CRYSTAL COMPOSITION INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11066602-B2 | Reactive mesogen and liquid crystal composition including the same | SPIN2B, ZYX, ZP1 | THRB 4397/4885RARB 255/4885RARA 452/4885 |
| US-10344213-B2 | Reactive mesogen and liquid crystal composition including the same | SCO2, CCNL2, CCNB2 | THRB 1799/4885RARB 2028/4885RARA 2289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.